Piermont Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-10,820
| Closed | -$206K | – | 211 |
|
|
2018
Q2 | $206K | Sell |
10,820
-1,910
| -15% | -$36.4K | 0.06% | 230 |
|
|
2018
Q1 | $215K | Sell |
12,730
-2,020
| -14% | -$34.1K | 0.07% | 230 |
|
|
2017
Q4 | $224K | Sell |
14,750
-810
| -5% | -$12.3K | 0.07% | 228 |
|
|
2017
Q3 | $279K | Sell |
15,560
-16,600
| -52% | -$298K | 0.09% | 223 |
|
|
2017
Q2 | $524K | Sell |
32,160
-5,640
| -15% | -$91.9K | 0.15% | 225 |
|
|
2017
Q1 | $529K | Hold |
37,800
| – | – | 0.13% | 226 |
|
|
2016
Q4 | $603K | Sell |
37,800
-740
| -2% | -$11.8K | 0.14% | 214 |
|
|
2016
Q3 | $641K | Buy |
+38,540
| New | +$641K | 0.15% | 208 |
|